LOS ANGELES, CA--(Marketwire - Sep 24, 2012) - MMRGlobal, Inc. ( OTCBB : MMRF ) ("MMR") today announced that the Company received another Notice of Allowance, or NOA. The patent will grant protection to the Company by allowing it to assert legal claims that any Web-based portal used for consumer access to personal health information covered by the patent constitutes an infringement of the Company's intellectual property, unless it is provided or licensed by the Company. The NOA, U.S. Serial No. 13/041,809 from the United States Patent and Trademark Office for its "Method and System for Providing Online Records," significantly expands the scope of the Company's existing health IT intellectual property for provisioning of Personal Health Records (PHRs) regardless of the healthcare professional providing the information.The patents come in advance of the Meaningful Use requirement that patients have online access to their protected health information through a Personal Health Record or other form of patient portal by 2014. The Company believes that this NOA makes it difficult for eligible healthcare professionals to fully qualify for incentives under the HITECH Act because one of the core requirements is to provide patients access to their personal health information through a Web-based portal.Accordingly, this patent could prevent EMR and PHR vendors from allowing patients access to personal health information without a license from MMR.

Robert H. Lorsch, MMRGlobal Chairman and CEO, said, "Since 2005, MMR has been building a Personal Health Record that seamlessly connects to any doctor or hospital regardless of the systems in the office, be it plain paper or the most advanced electronic medical records systems.This overriding patent will help protect the integrity of our products and raise the bar for PHRs while also making it extremely difficult to comply with certain Meaningful Use requirements under the HITECH Act without a license from MMR for the Company's IP.The NOA comes after nearly six years of effort and the expenditure of millions of dollars in technology on behalf of the Company's shareholders. The licensing of our health IT patent portfolio could mean a substantial ongoing revenue stream to the Company."

This patent will join the Company's patent numbers 8,117, 646; 8,117,045; and 8,121,855, and are directed toward the transmission of Personal Health Records and other protected health information to a PHR by fax or voice.MMRGlobal is a leading provider of Personal Health Records through its MyMedicalRecords PHR suite of products and services (www.mmrvideos.com) and also offers its MMRPro electronic document management and imaging systems for healthcare professionals (www.mmrprovideos.com).The Company also provides MyEsafeDepositBox storage solutions for consumers.The Company has more than 180 additional claims pending and applied for and is continuing to file additional claims under its global portfolio of Personal Health Record and document management and imaging patents.

According to Ted Ward of the law firm Liner Grode Stein Yankelevitz Sunshine Regenstreif & Taylor LLP (www.LinerLaw.com), which represents the Company as patent litigation counsel, "The MMR health IT Patent Portfolio means that anyone who provides a consumer with a Web-based portal, including hospitals, physicians and pharmacies, where the consumer can access personal health information may be infringing on MMR's IP."Ward added that Liner is in the process of contacting hundreds of hospitals and physician group practices to discuss opportunities to license the Company's IP in advance of 2014 Meaningful Use requirements to provide patients online access to their health information within four days of the information being available to the doctor and within 36 hours of being discharged from the hospital.

According to John Goodhue from McKee, Voorhees & Sease (www.ipmvs.com), patent counsel to the Company since filing of its first patents in 2005, "This is a highly significant addition to MMRGlobal's health IT patent portfolio, especially as it pertains to Personal Health Records, by helping the Company benefit from its early innovations in the industry."

Goodhue added, "The latest patent application is of potential relevance to numerous types of Personal Health Record portal offerings that allow users to privately manage and maintain their health records. This is further directed toward providing a Personal Health Record portal that can receive records from any healthcare provider and that allows a user to store and manage his or her records independently from their healthcare provider(s), such as by organizing the files into separate file folders."

The resulting patent will be a significant addition to the Company's Health IT patent portfolio which also includes previously issued patents and claims in the U.S. and patents issued, pending and applied for in countries of commercial interest including Australia, Singapore, New Zealand, and Mexico.

About MMRGlobal, Inc. MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal.MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId/Specifid vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit http://www.mmrglobal.com. View demos and video tutorials of the Company's products and services at http://www.mmrtheater.com.

Forward-Looking Statements All statements in this press release that are not strictly historical in nature, including potential intellectual property infringement claims, litigation or licenses, future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes of intellectual property infringement claims, litigation or licensing transactions, results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensors, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to claims of intellectual property infringement and litigation; maintaining, developing, monetizing and protecting our patent portfolio for both the Company's health IT and biotechnology intellectual property assets in the U.S. and internationally; timing of milestone payments in connection with licensing our IP; ability to establish and maintain strategic relationships; relationships with licensees; the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition, including variations in our quarterly operating results; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the 2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

See the article here:
MMRGlobal Receives Notice of Allowance for Dominant Game-Changing Personal Health Record Patent